CLX Clorox Company (The)

$99.32▲ +0.85% ConsumerStaples Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$12.01B
P/E Ratio
16.1
Div Yield
5.04%
52W Range
84.70 - 132.03
% vs 50 MA
2.27%
% vs 200 MA
-9.56%
RSI-14
59.5
MACD Histogram
+0.8000
Beta (1Y vs SPY)
0.26
Free Cash Flow
-$165.00M
Gross Rev
$1.67B
Gross Profit
$722.00M
EBITDA
$346.00M
COGS
$948.00M
Operating Exp
$438.00M
Operating Income
$284.00M
EBIT
$284.00M
Pretax Income
$256.00M
Net Income
$187.00M
EPS (Diluted)
1.54
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
AI Analysis
Generated May 28, 3:43 AM
Company Overview

The Clorox Company manufactures and markets a diverse portfolio of consumer and professional products globally, including well-known brands like Clorox, Pine-Sol, Glad, and Brita. Its strong brand recognition and market leadership in essential household and personal care categories provide a robust competitive position.

Bull Case
  • Clorox boasts a portfolio of essential, market-leading brands that typically experience stable demand regardless of economic cycles, providing pricing power and resilience.
  • The current P/E ratio of 15.8, coupled with the stock being 26.5% below its 52-week high, suggests a potentially attractive valuation for a quality consumer staples company.
  • As a consumer staples company, Clorox offers relative stability and resilience during periods of economic uncertainty, making it an appealing defensive play for investors.
  • Trading significantly below its 52-week high and both its 50-day and 200-day moving averages indicates potential for a rebound if market sentiment improves or the company delivers positive operational news.
Bear Case
  • Elevated input costs for raw materials, packaging, and logistics could continue to squeeze profit margins if the company struggles to fully offset them with price increases.
  • The consumer staples market is highly competitive, with pressure from private labels and other established brands, potentially limiting pricing power and market share growth.
  • As a mature company in a developed market, Clorox may struggle to achieve significant top-line revenue growth, making it reliant on cost management and market share gains.
  • The stock is trading below both its 50-day and 200-day moving averages, indicating a sustained downtrend and suggesting further technical weakness or resistance to upward movement.
Recent Performance

The stock is currently trading at $97.10, showing a modest daily gain of 0.9%. Despite this recent uptick, CLX remains significantly down by 26.5% from its 52-week high, indicating a substantial correction. Technically, the price is below both its 50-day and 200-day moving averages, signaling a persistent bearish trend, though the RSI of 53.0 suggests it is not in an oversold or overbought condition.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙